Abstract. A multiplex, real-time reverse transcription-polymerase chain reaction (RT-PCR) assay was developed that allowed simultaneous detection and rapid differentiation of vesicular stomatitis virus strainsNew Jersey (VSV-NJ) and Indiana 1, 2, and 3 (VSV-IN1-3). This assay involves use of a set of VSV universal primers located in the L gene that amplify VSV-IN1-3 and VSV-NJ using probes that allow differentiation of the major serotypes Indiana and New Jersey. The assay was evaluated using reference VSV, foot-and-mouth disease virus, swine vesicular disease virus, and vesicular exanthema of swine virus. To estimate diagnostic sensitivity, 159 epithelial samples collected between 1996 and 2002 from naturally infected cattle in Colombia were used. The assay cut off was calculated by testing RNA extracted from 150 virus-negative bovine tissues consisting of tongue, soft palate, muzzle, coronary band, and lymph node. All infected cattle were test positive for VS by results of real-time RT-PCR analysis; results for 156 of 159 (98.1%) agreed with the serotype determination from the complement-fixation test. Amplification did not occur in any of the negative bovine epithelial samples, allowing the cut-off values for the assay to be set. The real-time RT-PCR assay was documented to be sensitive and specific for the detection of VSV-NJ and VSV-IN (1-3) strains from field samples in a single reaction, thereby supporting use of this assay in the differential diagnosis of vesicular virus diseases in cattle.
Introduction
Vesicular stomatitis (VS) is an economically important disease of livestock throughout the Americas. Clinical signs of infection include vesicular lesions and ulcerations of the tongue, oral tissues, and coronary bands of infected cattle, swine, and horses. Except for its appearance in horses, it is clinically indistinguishable from foot-and-mouth disease (FMD), one of the most devastating viral infections of livestock. Laboratory diagnosis is required to differentiate between the 2 diseases. 4 The causal agent is a VS virus (VSV; family Rhabdoviridae, genus Vesiculovirus), of which it is the prototype. The VSV is a negative-sense, single-stranded, RNA virus with a genome of approximately 11 kb. There are 2 main serotypes, Indiana and New Jersey, with Indiana including subtypes 1-3. 5, 20 Vesicular stomatitis has been observed as recently as October 2005 in the USA, with cases of VSV-NJ infection being reported in Texas, New Mexico, Arizona, Utah, Wyoming, Montana, Idaho, Colorado, and Nebraska. It is known to be endemic to Ossabaw Island, Georgia, USA (VSV-NJ) 22 and to Central and South America where VSV-IN and VSV-NJ serotypes are observed. 16, 19 Infection with VSV-IN3 has been observed in Brazil, and VSV-IN2 infection occurs sporadically in southern Brazil and Argentina. 15 To rapidly determine which virus is the causal agent, the use of a well characterized real-time, reverse transcription-polymerase chain reaction (RT-PCR) assay would be beneficial. In conventional PCR or RT-PCR analyses, amplified products need to be processed at the end of the reaction and analyzed on the basis of size discrimination by use of agarose gel. In contrast, real-time assays collect data in the exponential growth phase of the PCR assay and allow more precise measurement of the amplified product to be made as the assay is in progress. Assays can be quantitative, assuming 100% efficiency of the reaction. They are representative of the initial amount of RNA present and allow detection over a larger dynamic range. An added benefit is that postprocessing of the end products is not required as the detection of the amplified products is observed while the reaction is occurring in real time. 2 This, along with shorter programs and cycling times for real-time PCR analytic machines, allows the duration required to obtain results to be shorter and, therefore, faster than that associated with conventional PCR analysis.
A multiplex, real-time RT-PCR assay for rapid and accurate diagnosis of VS was developed. This assay involves use of a set of VSV universal primers located in the L gene that amplify VSV-IN1-3 and VSV-NJ with probes that allow differentiation of the major serotypes Indiana and New Jersey. Other published assays only amplify VSV-IN1 and VSV-NJ, and are potentially more complicated and/or have not been tested on field samples. 7, 10, 12, 14, 17 
Materials and methods
Virus strains and RNA extraction. Using a commercial kit, a RNA was extracted from clarified cell lysates infected with one of the following viruses: VSV (VSV-IN1-3 and VSV-NJ serotypes), FMDV (serotypes O, A, C, Asia, SAT1, SAT2, and SAT3: 23 isolates in total), 23 isolates of swine vesicular disease virus (SVDV), 1 isolate of vesicular exanthema of swine virus (VEV), and 1 isolate of coxsackie B5 virus. One-hundred fifty-nine epithelial samples from naturally infected cattle of Colombia were received in vesicular disease transport media (0.03 M sodium phosphate, 0.006 M potassium phosphate, 0.003% phenol red, 50% glycerol, pH 7.6) and were stored at 220uC on arrival. All tissues were collected between 1996 and 2002 (11 in 1996, 26 in 1997, 31 in 1998, 14 in 1999, 47 in 2000, 29 in 2001, and 1 in 2002) . For RNA extraction from these samples, approximately 30 mg of tissue was processed using a commercial kit.
b The RNA also was extracted from 150 virus-negative bovine tissues consisting of tongue (n 5 35), soft palate (n 5 34), muzzle (n 5 26), coronary band (n 5 29), lymph node (n 5 22), or thymus (n 5 4) collected from a total of 40 animals.
Primer and probe design. The PCR primers were based on the VSV-IN sequence of the L gene, 1, 6, 7, 13, 21 and are located at nucleotides 7,230-7,254 for VSV Forward and at nucleotides 7,433-7,456 for VSV Reverse on the basis of Genbank accession number J02428. The PCR primers (Fig. 1) .
Real-time RT-PCR analysis. Two real-time, RT-PCR thermal cyclers, the ABI 7900 c and the Cepheid SmartCycler, d were compared to determine how well the assay worked on different platforms. One-step RT-PCR analysis was performed by use of a commercial kit e according to the manufacturer's instructions. Primers were added at a concentration of 0.2 mM. Probes were added at unequal concentrations, 0.2 mM of NJ-FAM minor groove binder (MGB) and 0.1 mM of IND-VIC-MGB, to produce an optimal reaction for both serotypes. Final reaction volumes were 25 ml, which included a 2-ml RNA sample volume. The protocol included a 30-minute RT step at 50uC, followed by a 1-minute denaturing/polymerase activation step at 95uC. A 3-cycle PCR program was used under the following conditions: 95uC for 15 seconds, 54uC for 30 seconds, and 72uC for 60 seconds for 45 cycles. The entire program took 2 hours to complete. Cycling conditions and the commercial kits used were identical for the 2 thermal cyclers.
Sample preparation and virus isolation. A 10% epithelial tissue suspension was prepared from selected samples that gave high Ct values (where Ct value is the cycle in which a significant increase in fluorescence above the threshold is measured) in the RT-PCR assay and/or gave contradictory results, compared with results of previously performed complement-fixation tests. Using a sterile mortar and pestle, tissue samples for suspensions were homogenized in Dulbecco's phosphate-buffered saline f (PBS) containing streptomycin (1 mg/ml), vancomycin (20 U/ml), nystatin (50 U/ml) and gentamycin (500 U/ml). Samples were clarified by centrifugation, then were inoculated onto monolayers of 3 cell lines (Vero cells, BHK-21 cells, and a primary lamb kidney cell line). Each epithelial suspension was inoculated onto 4 wells of a 24-well plate. Plates were incubated for 2 days at 37uC, after which they were examined for signs of cytopathic effect (CPE). If CPE was observed in any of the 4 wells, a double antigen-detection sandwich ELISA (DAS ELISA) was performed on the cell culture supernatant to confirm that the CPE was due to VSV infection, and the samples were considered VSV positive. If CPE was not observed, the plates were frozen at 270uC, then were thawed, and the material was passaged a second time in the same cell line. After 2 days, if CPE was still not observed in any of the wells, the samples were considered VSV negative. Virus isolation in Vero cells also was performed as described previously on serial dilutions of each of the prototypic strains VSV-IN1-3 and VSV-NJ to determine detection limits for comparison against real-time RT-PCR sensitivity.
Double antigen-detection sandwich ELISA. A DAS ELISA was performed by sensitizing a polystyrene microtitration plates g with a rabbit antiserum (100 ml/ well) produced against VSV-IN1-3 and VSV-NJ diluted in carbonate coating buffer (0.06 M, pH 9.5) overnight at 4uC. After 5 washes in washing buffer (0.01 M PBS, 0.05% Tween 20), either antigen controls or 10% tissue suspensions (100 ml each) in diluent buffer (0.01 M PBS, 0.05% Tween 20, 2% normal rabbit serum, 2% normal bovine serum, 0.04% phenol red) were added to duplicate wells that were incubated for 1 hour at 37uC with agitation.
For each control or sample, a control well without antigen also was used to control for background noise. After incubation, plates were washed 5 more times and 100 ml of guinea pig anti VSV-IN1-3 or VSV-NJ (all produced in house) in diluent buffer was added to the wells. After 30 minutes' incubation at 37uC with agitation, plates were washed 5 times with washing buffer, and 100 ml of horseradish peroxidase-conjugated donkey antiguinea pig IgG (H + L) h diluted 1:5,000 in diluent buffer was added to all wells. The plates were sealed and incubated at 37uC for 30 minutes with agitation. After washing 5 times, the chromogen solution o-phenylenediamine dihydrochloride (OPD) i was added and the plate was then shaken continuously in the dark at room temperature. Color development was stopped after 10 minutes with of 2 M sulfuric acid (100 ml/well).
The optical density (OD) was determined at 490 nm by use of an automated ELISA plate reader. Results were calculated on the basis of corrected OD values computed as the mean OD of the sample wells minus the mean OD of the control wells without antigen. Any value . 0.1 was considered a positive result.
Sequencing. The real-time RT-PCR products were sequenced for all VSV strains, 10 random VSV-NJ Colombian samples for probe sequence determination, and for sample 27525 because it had positive Ct values for VSV-NJ and VSV-IN. To identify which serotype of VSV was present in sample 27525, another primer set was used. 18 For all sequencing reactions, cycle sequencing was performed.
c Products were amplified by use of GeneAmp 9700 c following the manufacturer's recommended protocol of 96uC for 1 minute, followed by 25 cycles of 96uC for 10 seconds, 50uC for 5 seconds, and 60uC for 4 minutes. All cycle sequencing products were run using the 3130XL c and were analyzed by use of the accompanying software.
Results

Real-time RT-PCR specificity
All of the prototype VSV-NJ and VSV-IN strains (1-3) were successfully amplified by use of this assay on the Cepheid SmartCycler platform (Fig. 2) and the ABI 7900 platform, which produced data similar to the SmartCycler data. The NJ-FAM-MGB probe specifically recognized VSV-NJ, whereas the IND-VIC-MGB probe recognized VSV-IN1-3 strains. Using the ABI 7900 machine, there was a low level of fluorescence detected with the VSV-NJ probe in the VSV-IN2 virus sample. For determination of cutoff values of the assay, virus-negative bovine tissues (150) were tested. None crossed the threshold, thereby giving Ct values of 0 at 45 cycles. This allowed any sample that crossed the threshold and gave a Ct value to be considered as having a positive result. To determine the diagnostic specificity of the primers and probes in the assay, 23 FMDV isolates covering all 7 serotypes, 23 SVDV isolates, and 1 isolate each of Coxsackie B5 virus and VEV were tested. None crossed the background threshold, documenting the assay to be specific for VSV. 2 value is used to show the fit of the standards to a straight line, and should be as close to 1 as possible. The RNA concentrations of virus from the undiluted samples ranged from 50 ng/ ml for VSV-IN1, to 26 ng/ml for VSV-IN, to 21 ng/ml for VSV-IN3, and to 29 ng/ml for VSV-NJ. The detection limit based on virus isolation from identical serial dilutions used for the real-time RT-PCR assay was from 1.94 log 10 median tissue culture infective doses (TCID 50 )/ml for VSV-IN1 to 3.8 log 10 TCID 50 / ml for VSV-IN3. Table 1 shows the relationship between the serial dilutions, virus isolation results, and comparative sensitivity of the RT-PCR assay.
Assay evaluation
Of 159 virus-positive field samples tested, 158 (99%) yielded a positive result by use of the SmartCycler. Use of the ABI 7900 resulted in detection of all 159 positive samples. The Ct values were similar between the 2 platforms for each sample (Fig. 3) . There was excellent correlation between the Ct values for both platforms with each sample, as indicated by a correlation coefficient of 0.92 for VSV-IN and 0.95 for VSV-NJ (Fig. 4) . When these results were compared with the previous complement-fixation test results, all but 5 virus-positive samples were correctly serotyped by use of the real-time RT-PCR assay with the SmartCycler and, of these 5, four also were misidentified by use of the ABI 7900. One sample was consistently identified as VSV-IN and VSV-NJ by use of real-time RT-PCR analysis with both platforms. On the basis of these numbers, the correlation between the complement-fixation test and the RT-PCR assay was excellent, with Kappa values of 0.96 (Table 2 ) and 0.95 for the ABI 7900 and SmartCycler, respectively.
To further test these samples, the DAS ELISA was used. For 3 more of these samples, the ELISA results agreed with those of the real-time RT-PCR assay and the complement-fixation test (Table 3) . Because results of 2 of the 3 tests performed were in agreement, the serotype was most likely that identified by the real-time assay. The sample that was identified as VSV-IN and VSV-NJ by the real-time RT-PCR assay could not be serotyped by use of the ELISA. 
Virus isolation
Virus isolation was attempted on selected samples with Ct values . 30 or that were in disagreement between results of the complement-fixation test and the RT-PCR assay, or both. On the basis of World Organization for Animal Health (OIE) guidelines, the samples were made into 10% epithelial suspensions and inoculated onto 3 susceptible cell lines, Vero, BHK-21, and a primary lamb kidney cell line. However, virus isolation using these samples was unsuccessful, perhaps due to the age and storage condition of the epithelial samples.
Sequencing
The real-time RT-PCR product was sequenced for all VSV prototype strains and sample 27525. On comparison, sample 27525 was closest to the VSV-NJ strain using CLUSTAL (http://www.ebi.ac.uk/ clustalw/) for the alignment of the RT-PCR product. A nucleotide difference similar to that of the VSV-IN sequence was observed at position 12 of the probe region, which may, therefore, account for the detection by both probes. Amplification and sequencing with multiple primers for regions in the P gene also indicated closer similarity to VSV-NJ rather than to VSV-IN, with an identity of 82%.
Discussion
The newly developed real-time RT-PCR assay was designed to detect the L gene of VSV. The L gene does not appear to be the most conserved, 18 but another study indicated that the L gene has specific regions containing conserved motifs between the Indiana and New Jersey serotypes, 6 and that these regions may, therefore, be a good place for primer positioning when designing diagnostic assays. Sequence differences in these regions do not appear to be randomly distributed, but are in discrete areas. 18 The initial assay design was based on available sequences of VSV, and the probe design was based on the PCR sequence of the 227-bp product. For the design of the VSV-IN probe, the aligned PCR products of the prototypic laboratory strains of VSV-IN were used. Sequencing of PCR products from 10 random VSV-NJ samples from Colombia allowed the design of the New Jersey probe. Proper probe design is important, so that all samples can be correctly identified in the real-time RT-PCR assay. In a multiplex, real-time assay, the fluorophores for the probes need to be chosen so that the absorption and emission spectrums are significantly different between the 2 labels, therefore resulting in maximal sensitivity of the assay with the least amount of crosstalk. To this end, FAM and VIC fluorophores were chosen as the 59 labels for the probes. Nonfluorescent minor groove binders (MBG) were added to the 39 end of each probe as they have a number of advantages. The last 3 bases of the probe located just 59of the MGB are the most important for the binding of the probe to the sequence, and therefore, help impart specificity. The MGB also allows use of shorter probes as it increases the annealing temperature at which the probe binds to the sequence. This is an advantage when dealing with sequences that are poorly conserved between strains and where the annealing temperature of a probe would be too low to allow the assay to work well otherwise. 8 For the serotype-specific probes in this assay, the IND-VIC-MGB probe contains 4 sequence mismatches to the VSV-NJ sequence and 1 to VSV-IN2, but is still able to recognize VSV-IN2. The NJ-FAM-MGB probe contains 7 mismatches to VSV-IN1 and 5 to each of VSV-IN2 and 3. Most of the mismatches in each probe are located in the second half of the probes, closer to the MGB.
Values for R 2 are used to determine how well the standards amplify and fit to a straight line and should be as close to 1 as possible. The universal primers were based on the VSV-IN1 sequence, thereby resulting in the highest R 2 of 1 for VSV-IN. The value for VSV-IN2 and 3 and for VSV-NJ also were high, with respective values of 0.996, 0.997, and 0.997. For 100% efficiency, the slope value should be -3.32. An acceptable range would give values of $90% efficiency, resulting in slope values of -3.58 to -3.32. Values for this assay ranged from -3.396 (efficiency of 97.0%) to -3.467 (efficiency of 94.3%). Overall, this is a robust reaction with excellent efficiency for all strains and it worked well on both real-time PCR platforms. The benefit of having an assay that will work on more than 1 platform without needing any changes allows the use of either platform. The SmartCycler is slightly faster and is excellent for use with smaller sample numbers. For a higher throughput assay, the ABI 7900 has the advantage of being able to run more samples at once, though it requires a slightly longer test time.
Comparative sensitivity of isolation with the real-time RT-PCR assay was tested using the laboratory strains of VSV-IN1-3 and VSV-NJ. Isolation was as sensitive as the RT-PCR assay for VSV-IN1 and VSV-NJ. In this instance, isolation was more sensitive for VSV-IN2 and VSV-IN3. It is important to note that the laboratory strains are highly adapted to cell culture, and therefore, will perform exceptionally well in an isolation assay. This will not be indicative of the way a field isolate to be tested would behave for virus isolation. All of the naturally infected cattle that were tested by virus isolation had negative results. This was most likely due to the age and storage conditions of the samples.
The results indicated that the assay is specific for VSV-NJ and VSV-IN. The prototype strains were correctly serotyped and identified, and all negative controls failed to show any amplification for either platform. Essentially, any fluorescence resulting in a Ct value can be viewed as a positive result for this assay. There was a low level of fluorescence associated with VSV-IN2 in the ABI 7900 machine. To alleviate this, the threshold could be increased, but it might result in decreased sensitivity. It is better to have the increased sensitivity of the assay, as the VSV-IN2 curve is low and flat, making it easy to differentiate VSN-IN serotypes from the true VSV-NJ serotypes.
When used for samples from naturally infected cattle, the assay had excellent agreement with the complement-fixation test, as shown by a Kappa value close to 1. The samples were selected across a 7-year span and were collected from various regions of Columbia to account for possible genetic variation. It is thought that RNA viruses readily mutate, and observations to that effect have been made in tissue culture studies. 9, 21 Other studies have indicated that actual recombination rates may be lower than was previously believed, 3 and that the genetic stability of the viral genome is high, even over a span of 30 years. 11, 16 Results for most samples that yielded contradictory results between the complement-fixation test and real-time RT-PCR assay, when tested by ELISA, were in agreement with those of the real-time assay. As the ELISA and real-time RT-PCR assays were in agreement, it is not clear how these samples were misclassified in the complement-fixation test. One sample gave inconsistent serotype results with the RT-PCR assay itself and among the RT-PCR assay, complement-fixation test, and ELISA. The RNA was extracted on 4 occasions and consistently yielded a positive result with both probes in the realtime assay. That sample had negative results of virus isolation and the ELISA, but was found to have a New Jersey serotype by use of complement fixation. It is possible that the sample may have come from an animal with a mixed infection or that the nucleotide change in the probe binding site is sufficient for the VSV-IN probe to bind. Sequencing data indicated that the closest homology was to VSV-NJ, on the basis of sequencing of the RT-PCR product and a larger P gene region.
Real-time assays are specific and rapid and make excellent diagnostic tools. This real-time RT-PCR assay is uncomplicated and easy to use. It requires only 1 set of universal primers and has specific probes for the correct identification of the serotype of the VSV in a given sample. As it is a single, closed-tube, one-step assay, less time is spent on manual manipulation of the samples, such as postprocessing analysis of the PCR products. The test itself is rapid and takes only 3 to 4 hours (including RNA extraction) to obtain a serotyping result. Previous PCR assays for VSVs involve use of conventional PCR techniques with different primers to determine the serotype, so that multiple PCR assays need to be performed on each sample and the PCR products need to be confirmed by use of agarose gel electrophoresis. 7, 10, 12 Thus far, there are a minimal number of real-time assays in literature for comparison. 14 This real-time RT-PCR assay proved to be sensitive and specific for the detection of VSV-NJ and VSV-IN (1-3) in a single reaction. More extensive validation, including testing of field samples of distinct genetic lineages and broad geographic origin will be needed to evaluate the full potential of this assay.
